Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial. - Paulina

Login with Wikimedia

Login with your Wikimedia account to add/edit data Login

Missing/wrong data? Log in to edit

Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.

scientific article published on 17 November 2017

Author/s

author: Jianping Jia, Vesna Vuksanović, Charles Harrington, Peter Bentham

Work details

Publication date

January 1, 2018

Copyright status

copyrighted